Equity Research, Broker Reports, and media content on SANOFI

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about SANOFI
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on SANOFI. We currently have 10 research reports from 1 professional analysts.

Open
87.7
Volume
3.1m
Range
87.7/89.4
Market Cap
115,467,278,019m
52 Week
62.5/89.4
Date Source Announcement
22May17 22:52 GNW Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients
19May17 12:09 GNW Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
10May17 17:19 GNW Sanofi: Annual General Shareholders' Meeting of May 10, 2017
28Apr17 06:30 GNW Sanofi Delivers Robust Q1 2017 Financial Results
28Apr17 06:00 GNW Sanofi and Regeneron Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by US FDA
24Apr17 06:00 GNW Sanofi and Regeneron Receive CHMP Positive Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
11Apr17 21:31 GNW Sanofi: Availability of the Pre-quarterly Results Communication
  • Frequency of research reports

     

  • Research reports on

    SANOFI

  • Providers covering

    SANOFI